CAR-TCR Summit coverage to track novel CAR-T Cell Therapies for B-Cell Malignancies

Case Study of the Assessment Novel CAR-T Cell Therapy for B-Cell Malignancies
Scope & Objective:

A large US base Pharma Company, wanted DelveInsight to support them by providing a detailed CAR-TCR Summit coverage of novel CAR-T Cell Therapies for the B-Cell Malignancies, including the emerging product analysis, developmental activities, safety and efficacy data, product milestones, future plans and KOL insights.

Congress Coverage Support:
  • DelveInsight supported the client by creating a focused conference coverage plan in order to gain in-depth assessment of the novel CAR-T Cell Therapies
  • In addition to this DelveInsight also conducted primary research in order to cater the KOL and Stakeholder insights around the cell therapy
  • High-priority sessions were selected for more focused live coverage
Congress Plan:
  • The team extracted and classified sessions by priorities
  • Captured detailed presentations and understand the business insights
  • KITs and KIQs were aligned with the client’s strategic needs
  • The deliverables enabled the client to proactive response to competitor activities in the B-Cell Malignancies disease area presented at CAR_TCR Summit
  • Senior internal stakeholders were timely informed of the latest business updates

Related Insights

In-Licensing Opportunity
In-Licensing Opportunity

A large client based in USA, involved in drug delivery devices, with effective marketing and commercialization presence across the globe, wanted to in-license potential dMTS based drug delivery asset... [...]

View Case
Out Licensing Opportunity
Out-Licensing Opportunity

A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from acr... [...]

View Case
Go-To-Market Strategy
Go-To-Market Strategy

A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes and strategies to launch their biosimilar in Europe... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.